Alpha 2.0
Login Register
» Authors » Kenichi Okudaira

Kenichi Okudaira

Explore the profile of Kenichi Okudaira including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 36
Followers 0
Related Specialties
Psychiatry
Neurology
General Medicine
Top 10 Co-Authors
Toshihiko Matsumoto
Nobuya Naruse
Takeshi Ashizawa
Nobuaki Morita
Tetsuji Cho
Kyohei Konuma
Sachio Matsushita
Takeo Muto
Aro Ino
Keiko Endo
Published In
Nihon Arukoru Yakubutsu Igakkai Zasshi
Psychiatry Clin Neurosci
Ryoikibetsu Shokogun Shirizu
Addiction
Seishin Shinkeigaku Zasshi
Affiliations
Soon will be listed here.
Recent Articles
1.
[Risk and sex factor on suicide among substance use disorder patients]
Matsumoto T, Matsushita S, Okudaira K, Naruse N, Cho T, Muto T, et al.
Seishin Shinkeigaku Zasshi . 2013 Dec; 115(7):703-10. PMID: 24288821
No abstract available.
2.
Sex differences in risk factors for suicidality among Japanese substance use disorder patients: association with age, types of abused substances, and depression
Matsumoto T, Matsushita S, Okudaira K, Naruse N, Cho T, Muto T, et al.
Psychiatry Clin Neurosci . 2012 Jul; 66(5):390-6. PMID: 22834657
Aim: The aim of this study was to identify risk factors for suicide in Japanese substance use disorder (SUD) patients, adjusting for age and sex, and to examine sex differences...
3.
Depression and suicide risk of outpatients at specialized hospitals for substance use disorder: comparison with depressive disorder patients at general psychiatric clinics
Matsumoto T, Matsushita S, Okudaira K, Naruse N, Cho T, Muto T, et al.
Nihon Arukoru Yakubutsu Igakkai Zasshi . 2012 Mar; 46(6):554-9. PMID: 22413563
The present study used a self-reporting questionnaire to compare suicide risk in outpatients being treated for substance use disorder at specialized hospitals to suicide risk in outpatients being treated for...
4.
[A study on differences of suicide risk in substance use disorder patients by types of an abused substance: a comparison among alcohol, amphetamine, and sedative, hypnotic or anxiolytic use disorder patients]
Matsumoto T, Matsushita S, Okudaira K, Naruse N, Cho T, Muto T, et al.
Nihon Arukoru Yakubutsu Igakkai Zasshi . 2011 Mar; 45(6):530-42. PMID: 21387609
Background And Purpose: Substance use disorder is one of the important mental health problems related to suicide, nearly equal with depressive disorder. However, it is unclear how differences of abused...
5.
Profiles associated with treatment retention in Japanese patients with methamphetamine use disorder: preliminary survey
Kobayashi O, Matsumoto T, Otsuki M, Endo K, Okudaira K, Wada K, et al.
Psychiatry Clin Neurosci . 2008 Oct; 62(5):526-32. PMID: 18950371
Aims: To identify profiles associated with treatment retention in Japanese patients with methamphetamine use disorder. Methods: The study used a retrospective design based on clinical records. The subjects were 101...
6.
[A preliminary study on outpatient relapse prevention program for methamphetamine dependent patients: Serigaya Methamphetamine Relapse Prevention Program (SMARPP)]
Kobayashi O, Matsumoto T, Otsuki M, Endo K, Okudaira K, Harai H, et al.
Nihon Arukoru Yakubutsu Igakkai Zasshi . 2007 Dec; 42(5):507-21. PMID: 18051470
Although methamphetamine use disorder has been prevalent in Japan for more than fifty years, there have been hardly any effective medical treatment modalities other than improving methamphetamine-induced psychosis through hospitalization...
7.
[Late withdrawal syndrome]
Okudaira K
Ryoikibetsu Shokogun Shirizu . 2003 Nov; (40):429-31. PMID: 14626153
No abstract available.
8.
[Early withdrawal syndrome]
Okudaira K
Ryoikibetsu Shokogun Shirizu . 2003 Nov; (40):426-8. PMID: 14626152
No abstract available.
9.
Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration
Matsumoto T, Kamijo A, Miyakawa T, Endo K, Yabana T, Kishimoto H, et al.
Addiction . 2002 Jul; 97(7):809-17. PMID: 12133119
Aims: To determine differences in life backgrounds and clinical features between methamphetamine (MAP) smokers and injectors in Japan. Setting: Out-patient clinic at a psychiatric centre. Participants: Among 451 MAP abusers...